NCT05987813

Brief Summary

This study is to determine if the auricular microstimulator produces the expected increase in HRV.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

October 18, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 4, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 4, 2024

Completed
7 months until next milestone

Results Posted

Study results publicly available

December 27, 2024

Completed
Last Updated

December 27, 2024

Status Verified

December 1, 2024

Enrollment Period

8 months

First QC Date

August 4, 2023

Results QC Date

November 4, 2024

Last Update Submit

December 4, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in High-frequency Heart Rate Variability (hfHRV) at 4 Weeks

    Determine if microstimulation over a 4 week period results in improvement in hfHRV power. Average hfHRV power was calculated at baseline and 4 weeks. The change in average hfHRV power in milliseconds squared from baseline to 4 weeks was calculated for each participant. The average change for each group is reported.

    Assessed at baseline and 4 weeks.

  • Rate of Compliance With Daily TENS Usage

    Determine the compliance rate of adolescents utilizing a microstimulator. Compliance rate calculated as number of minutes unit was used (summed from all self-report daily recording journals) divided by 3360 (the total number of minutes the unit could have been used if the participant used it for 2 hours daily for 4 weeks). The rate average for each group is reported.

    Assessed daily for duration of study (4 weeks) via self-report recording journal.

Study Arms (2)

FGID

EXPERIMENTAL

Patients with a FGID

Device: TENS Unit

Non-FGID

EXPERIMENTAL

Patients without a FGID

Device: TENS Unit

Interventions

TENS UnitDEVICE

Usage of the Transcutaneous Electrical Nerve Stimulation device for 2 hours a day.

FGIDNon-FGID

Eligibility Criteria

Age12 Years - 21 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Female
  • years old
  • Either diagnosed OR not diagnosed with chronic idiopathic nausea, functional abdominal pain, dyspepsia and/or irritable bowel syndrome.
  • English speaking

You may not qualify if:

  • Patients who are unable to stand upright during the heart rate variability recording
  • Patients with a known bleeding disorder
  • Patients with swollen, infected, inflamed, or other skin eruptions on outer ear
  • Patients with epilepsy
  • Patients with any implanted cardiac pacemaker or defibrillator
  • Patients with serious arterial circulatory problems in the lower limbs
  • Patients with abdominal or inguinal hernia
  • Patients who are pregnant
  • Any unstable medical condition, such as renal disease, uncontrolled diabetes, etc.
  • Requires new medication during the 4 weeks of the study that may affect the gastrointestinal symptoms, vagal modulation or immune response.
  • Practices over 1 hour of aerobic activity a day
  • Daily practice of abdominal breathing (yoga)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virginia Commonwealth University

Richmond, Virginia, 23219, United States

Location

Related Publications (15)

  • Hyams JS, Davis P, Sylvester FA, Zeiter DK, Justinich CJ, Lerer T. Dyspepsia in children and adolescents: a prospective study. J Pediatr Gastroenterol Nutr. 2000 Apr;30(4):413-8. doi: 10.1097/00005176-200004000-00012.

    PMID: 10776953BACKGROUND
  • APLEY J, NAISH N. Recurrent abdominal pains: a field survey of 1,000 school children. Arch Dis Child. 1958 Apr;33(168):165-70. doi: 10.1136/adc.33.168.165. No abstract available.

    PMID: 13534750BACKGROUND
  • Boey C, Yap S, Goh KL. The prevalence of recurrent abdominal pain in 11- to 16-year-old Malaysian schoolchildren. J Paediatr Child Health. 2000 Apr;36(2):114-6. doi: 10.1046/j.1440-1754.2000.00465.x.

    PMID: 10760006BACKGROUND
  • Enck P, Aziz Q, Barbara G, Farmer AD, Fukudo S, Mayer EA, Niesler B, Quigley EM, Rajilic-Stojanovic M, Schemann M, Schwille-Kiuntke J, Simren M, Zipfel S, Spiller RC. Irritable bowel syndrome. Nat Rev Dis Primers. 2016 Mar 24;2:16014. doi: 10.1038/nrdp.2016.14.

    PMID: 27159638BACKGROUND
  • Riganello F, Garbarino S, Sannita WG. Heart Rate Variability, Homeostasis, and Brain Function. J Psychophysiol. 2012; 26: 178- 203.

    BACKGROUND
  • Goldstein DS, Bentho O, Park MY, Sharabi Y. Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Exp Physiol. 2011 Dec;96(12):1255-61. doi: 10.1113/expphysiol.2010.056259. Epub 2011 Sep 2.

    PMID: 21890520BACKGROUND
  • Reyes del Paso GA, Langewitz W, Mulder LJ, van Roon A, Duschek S. The utility of low frequency heart rate variability as an index of sympathetic cardiac tone: a review with emphasis on a reanalysis of previous studies. Psychophysiology. 2013 May;50(5):477-87. doi: 10.1111/psyp.12027. Epub 2013 Feb 27.

    PMID: 23445494BACKGROUND
  • Liu Q, Wang EM, Yan XJ, Chen SL. Autonomic functioning in irritable bowel syndrome measured by heart rate variability: a meta-analysis. J Dig Dis. 2013 Dec;14(12):638-46. doi: 10.1111/1751-2980.12092.

    PMID: 23927739BACKGROUND
  • Jarrett M, Heitkemper M, Czyzewski D, Zeltzer L, Shulman RJ. Autonomic nervous system function in young children with functional abdominal pain or irritable bowel syndrome. J Pain. 2012 May;13(5):477-84. doi: 10.1016/j.jpain.2012.02.007. Epub 2012 Apr 20.

    PMID: 22520688BACKGROUND
  • Evans S, Seidman LC, Tsao JC, Lung KC, Zeltzer LK, Naliboff BD. Heart rate variability as a biomarker for autonomic nervous system response differences between children with chronic pain and healthy control children. J Pain Res. 2013 Jun 12;6:449-57. doi: 10.2147/JPR.S43849. Print 2013.

    PMID: 23788839BACKGROUND
  • Williams DP, Chelimsky G, McCabe NP, Koenig J, Singh P, Janata J, Thayer JF, Buffington CA, Chelimsky T. Effects of Chronic Pelvic Pain on Heart Rate Variability in Women. J Urol. 2015 Nov;194(5):1289-94. doi: 10.1016/j.juro.2015.04.101. Epub 2015 May 9.

    PMID: 25963185BACKGROUND
  • Mork PJ, Nilsson J, Loras HW, Riva R, Lundberg U, Westgaard RH. Heart rate variability in fibromyalgia patients and healthy controls during non-REM and REM sleep: a case-control study. Scand J Rheumatol. 2013;42(6):505-8. doi: 10.3109/03009742.2012.755564. Epub 2013 Feb 20.

    PMID: 23425526BACKGROUND
  • Terkelsen AJ, Molgaard H, Hansen J, Finnerup NB, Kroner K, Jensen TS. Heart rate variability in complex regional pain syndrome during rest and mental and orthostatic stress. Anesthesiology. 2012 Jan;116(1):133-46. doi: 10.1097/ALN.0b013e31823bbfb0.

    PMID: 22089824BACKGROUND
  • Kang JH, Chen HS, Chen SC, Jaw FS. Disability in patients with chronic neck pain: heart rate variability analysis and cluster analysis. Clin J Pain. 2012 Nov-Dec;28(9):797-803. doi: 10.1097/AJP.0b013e3182442afd.

    PMID: 22751023BACKGROUND
  • Chelimsky G, Rausch S, Bierer D, Feng M, Simpson P, Awe E, Chelimsky T. Cardiovagal modulation in pediatric functional gastrointestinal disorders. Neurogastroenterol Motil. 2019 May;31(5):e13564. doi: 10.1111/nmo.13564. Epub 2019 Mar 27.

    PMID: 30916860BACKGROUND

MeSH Terms

Conditions

Gastrointestinal Diseases

Condition Hierarchy (Ancestors)

Digestive System Diseases

Results Point of Contact

Title
Gisela Chelimsky
Organization
Virginia Commonwealth University

Study Officials

  • Gisela Chelimsky, MD

    VCU

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: FGID group, non-FGID group. Assigned to 2 hours of daily TENS usage
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2023

First Posted

August 14, 2023

Study Start

October 18, 2023

Primary Completion

June 4, 2024

Study Completion

June 4, 2024

Last Updated

December 27, 2024

Results First Posted

December 27, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Anonymized information may be shared to other researchers for future relevant projects.

Locations